Account Info
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
VXLLF VAXIL BIO LTD (CA)
0.0160.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
0 0 0 0
Operating revenue
-- 0 -- 0 -- 0 -- 0
Cost of revenue
Gross profit
Operating expense
-41.84% 139K -30.14% 146K -51.16% 126K -26.80% 986K
Selling and administrative expenses
-41.86% 50K -62.28% 43K -57.53% 62K -40.88% 428K
-General and administrative expense
-41.86% 50K -62.28% 43K -57.53% 62K -40.88% 428K
Research and development costs
-41.45% 89K 8.42% 103K -44.14% 62K -12.92% 539K
Depreciation amortization depletion
-- 0 -- 0 100.00% 2K 375.00% 19K
-Depreciation and amortization
-- 0 -- 0 100.00% 2K 375.00% 19K
Operating profit
41.84% -139K 30.14% -146K 51.16% -126K 26.80% -986K
Net non-operating interest income expense
0
Non-operating interest expense
-- -- -- -- -- -- -- 0
Other net income (expense)
Income before tax
41.84% -139K 30.14% -146K 51.16% -126K 27.39% -986K
Income tax
Net income
41.84% -139K 30.14% -146K 51.16% -126K 27.39% -986K
Net income continuous Operations
41.84% -139K 30.14% -146K 51.16% -126K 27.39% -986K
Minority interest income
Net income attributable to the parent company
41.84% -139K 30.14% -146K 51.16% -126K 27.39% -986K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.84% -139K 30.14% -146K 51.16% -126K 27.39% -986K
Basic earnings per share
41.97% -0.001 89.34% -0.0011 52.23% -0.0009 0.00% -0.01
Diluted earnings per share
41.97% -0.001 89.34% -0.0011 52.23% -0.0009 0.00% -0.01
Dividend per share
Currency Unit
CADCADCADCAD
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: Dr. Yuval Avnir
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist